Here’s what you should know.
1. ESG can delay gastric emptying, induce early satiation and reduce body weight.
2. Although bariatric surgery is the most effective surgical option, patients have limited access to it because of the surgery’s risks and associated costs.
3. ESG uses a full-thickness endoscopic suturing device to reduce the gastric reservoir. Patients require general anesthesia and occasionally an overnight observational stay.
4. In a clinical trial, 25 obese individuals underwent ESG with “endoluminal creation of a sleeve along the gastric lesser curve and were followed for a media period of nine months.”
5. Researchers found that the subjects lost 53 percent ± 17 percent of excess body weight six months after the procedure, and maintained a 45 percent ± 41 percent loss 20 months after the procedure.
6. Patients did experience significant delays — up to 90 minutes — in gastric emptying, however.
7. The researchers concluded “for endoscopic bariatric therapy to have a meaningful effect on obesity, it should reach a threshold of efficacy that is balanced with risk and cost of the intervention.”
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Bitman Stewart of Digestive Care
Integrated Endoscopy seeks $4.4M for executive compensation: 3 key notes
Hallmark Health Medical Associates names gastroenterologist Dr. Michael Newman president: 3 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.